Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
BIOECONOMY
INDUSTRY
2.7%
and is estimated to contribute 2.7% to global Various policies have been introduced National Bioplastic Roadmap
GDP by 2030.2 to address technological, economic
and institutional challenges to move A national agenda to establish
the country towards a sustainable a complete supply chain for the
biobased economy. bioplastic industry in Thailand. The
policy focused on the development
of R&D, supporting infrastructure
2004-2021 and innovative businesses for
bioplastics.
Thailand’s National Biotechnology
Plant Breeding Diagnostic Kits
Bioenergy Framework
Development
Biochemicals
Stem Cell Technology The framework includes a policy 2012-2036
Animal Farming of Green Innovations for Economic
Biopharma- Alternative Energy Development
Biofuels Security, Competitiveness and a
Diagnosis of Diseases ceuticals Plan
Healthy Society and targets 4 critical
sectors: Food and Agriculture, This plan aims to cut the country’s
Medicine and Health, and Bioenergy dependence on imported fossil
Agriculture Industry Health and Biobased Industries. fuels with domestically produced
renewable energy.
The new “Thailand 4.0” growth model focuses on the concept of inclusive,
productive and green growth to enhance the country’s competitiveness and
economic development. Under the model, 10 industries are issued as the
new economic growth engines of which the five new industries are Robotics,
Medical Hub, Aviation and Logistics, Digital and Bioeconomy.
Bioenergy Consumption
Bioeconomy - BIOENERGY
a National Agenda
Energy consumption in Thailand
As one of the new economic growth > 70 million tons > US$8.67 billion*/year
increased by about 4% since 2010*.
engines, the Ministry of Industry gives Total energy expenditure in 2014 was
a precedence to bioeconomy, utilizing US$63.23 billion**, 2.6% higher than
Thailand’s rich biodiversity and strong Increase in Income Cassava Value in 2013. The country is also heavily
chemical manufacturing industry. for Farmers Added dependent on imported energy, with
over 57% of energy purchased from
Moreover, the National Science overseas sources in 2014.1 Reducing
Technology and Innovation Policy Office the country’s dependence on foreign
(STI) works together with the National energy sources is one of the focuses of
Center for Genetic Engineering and the government to strengthen economic
Biotechnology (BIOTEC) to formulate stability. The country’s first alternative
the National Biotechnology Policy energy plan was introduced in 2012
Framework 2012-2021. The policy Increase to US$ > US$2.89 billion*/year to address energy concerns through
framework’s objectives are to develop 1,868 - 2,443*/year renewable alternatives and bioenergy.
strategic planning, establish future
R&D, and enhance the country’s
ability to access new technologies and Employment Rate BioEnergy
applications of biotechnology. Source:
1
Energy Policy and Planning Office,
The framework includes 4 different Ministry of Energy
Note:
sectors which are agriculture and food,
* Compound Annual Growth Rate (2010-2014)
medical and public health, bio energy, ** Exchange Rate = THB 34.80/US$
and bio industries. as of 1st September 2016;
Sugarcane
>30 million kilotons of
>300,000 Households
oil equivalent (ktoe)
Cassava
(in 20 years)
>500,000 Households
Source:
1
The National Center for Genetic Engineering
and Biotechnology (BIOTEC)
Note:
* Exchange Rate = THB 34.80/US$
as of 1st September 2016
Bioenergy Domestic
Consumption: 2014 & 2036F1
2014 2036
2% 1% 1%
5%
8%
18%
5% 18% 1% Democratic Republic and Australia. palm oil crushing mills and smallholder
farmers in the south of Thailand for the
Roundtable on Sustainable Palm Oil
Biofuels Bioheat Bioelectricity
(RSPO) certification and raising the Thai
palm oil industry to global standards.
Other Key Players
Thailand is the ASEAN leader in biofuels production with over 3.5 million Company Name Main Products
liters of ethanol and 3.3 million liters of biodiesel produced daily.2 In 2014,
biobased energy already accounted for approximately 9% of total energy Sugar, molasses, pulp, bio fertilizer,
Kaset Thai International
consumed in Thailand.3 Sugar Corporation
ethanol, electricity, and agricultural
machinery services
created reduced
Biochemistry covers a wide range Sugar Cane Sugar Cane Mill
of scientific disciplines, including
Feedstock
1.1 million rai 11 million tons/year
genetics, microbiology, plant science
30%
and pharmaceuticals. Because of its BDO** BSA*** Lactic Acid
Biochemicals
928USD
comprehensive breadth, there is the 100 kilotons/year 205 kilotons/year 330 kilotons/year
continuous need for development and Growth
research for new applications and Income expected in the
PLA PBS
potential market opportunities. per year Bioplastics Bioplastics
market 250 kilotons/year 100 kilotons/year
25%
Fatty Acids/Alcohol PBS ready-meal packaging by 25% of current usage.4
(Polybutylene Succinate)
Oleochemicals
Source:
PLA 1,4
Public-Private Partnership
Surfactants (Polylactic Acid) 2,3
Petroleum Institute of Thailand
Note:
* Exchange Rate = THB 34.80/ US$
Lactic Acids PBAT as of 1st September 2016
(Polybutyrate) ** BDO = 1.4-Butanediol
BDO *** BSA = Bovine serum albumin
(Butanediol)
PHA/PHB
(Polyhydroxyalkanoate/
Succinic Acids Polyhydroxybutyrate)
Source:
1
Petroleum Institute of Thailand
Note:
* Exchange Rate = THB 34.80/US$
as of 1st September 2016
Successful Companies
Corbion is the global leader in lactic bag production. Established in 1995, the
acid, lactic acid derivatives and lactides. company has expanded its operation to
With its largest production plant based five factories with an annual production
in Thailand, Corbion will be able to capacity of over 24,000 tons of plastic Pharmacy
leverage the plentiful sugar resources bags. Trusted by customers worldwide, BIOPHARMACEUTICAL &
Fine Chemicals
VO
available to become the largest PLA the company’s biodegradable plastic
UE
Food and Feed
L
producer in the world. To accelerate bag, MBIO-2, is certified by four Thailand aims to become ASEAN’s
UM
VA
its growth in the bioplastic arena, the international certification bodies; Biopharmaceuticals and Advanced
E
company will invest over US$100 DIN CERTCO (Germany), VINCOTTE Vaccine Hub by 20261 and join the US$1 Chemicals and Materials
million* in its new PLA polymerization (Belgium), FSWA (Finland) and BPI trillion global pharmaceuticals supply
and Lactide plants, which will open (USA). chain.2 Energy: Biofuels, Electricity and Heat
for operations in late 2018. The plant
will increase global PLA production In 2016, Multibax established a Over 14.6 million patients across ASEAN
capacity by a further 75 kilo tons per co-research project with Burapha and 98% of Thai patients are unable to Research in Vaccine Development
annum. University, the Biodiversity-Based afford imported medicines.3 To reduce
Economy Development Office (BEDO) their costs, Thailand aims to decrease With high-caliber researchers, vaccine
and the National Research Council of its import dependency by 30% and developers and a vast amount of
Thailand (NRCT) to set up a pilot scale increase its pharmaceutical export value agencies working in the field of
production for BioSuccinic acid, the to over 75,000 million Thai baht within vaccine research and development,
Multibax is an award-winning, world- starting material for PBS (BioPlastic the next 10 years.4 Thailand is now becoming the leader of
class plastics manufacturing company resin) production. vaccine development in ASEAN. Some
specializing in biodegradable plastic This US$63.22 million industry*,5 requires successfully developed projects include
intensive R&D and technological 5-in-1 or ‘cocktail’ vaccine, H5N1 avian
Other Key Players investments to achieve its ambitious influenza vaccine, dengue vaccine.
goals. This presents an enormous
Manufactures and sells Oleochemical and Fatty Alcohol products, which
Thai Fatty Alcohol are used for producing home and personal care opportunity for foreign investors Dengue Vaccine
to explore the market and enjoy NSTDA researchers have also
Provider of fatty alcohol ethoxylate, a key ingredient in the manufacture of tremendous growth potential. Moreover, developed a dengue vaccine to address
various personal hygiene products Thailand has developed several and prevent dengue fever, the disease
biotechnology programs, especially of high fatality rate. The vaccine is
Produces methyl ester, which is used as an ingredient in biodiesel in alternative disease solutions, for aimed for use in indigenous population
many emerging and tropical diseases. as well as populations along Thailand’s
Provider of starch derivatives, used as an ingredient in food, cosmetic, and Thailand has successfully developed border regions.
pharmaceutical products
number of vaccines, including tetanus,
pertussis, and hepatitis B. The country 5-in-1 or ‘Cocktail’ Vaccine
Provider of compostable bioplastic material with fast tracking solution for customer
is also one of the leading countries in Many vaccines have been developed by
stem cell research in Southeast Asia. the Thailand’s NSTDA in collaboration
Provider of bio-plastic resins and products with BIONET Asia. For instance, the 5-in-
1 or ‘Cocktail’ vaccine against 5 major
Source:
World-class provider of food additive, including food grade Citric Acid and Citrate 1, 3
Council of University Presidents of Thailand
infectious diseases, diphtheria, tetanus,
( CUPT ) pertussis, hepatitis B, and meningitis
Provider of citric acid
2
Thomson Reuters has been successfully developed and is
Thai Citric Acid
4, 5
D5 working team under Thailand’s expected to be released to the market
Note: * Exchange Rate = Euro 0.89/US$ as of 1st September 2016 Public-Private Partnership; in 2017.
Note: * Exchange Rate = THB 34.8/ US$
as of 1st September 2016
WHY INVEST IN
THAILAND? 1st
World’s No.1
exporter
cardiovascular disease and provide Abundant Resources and of cassava
H5N1 Avian Influenza other benefits typically associated with Biodiversity products
As part of the National Flu Pandemic utilizing prescription drugs. Thailand
Preparedness Plan, the GPO H1N1 is making a great deal of progress Thailand’s rich natural resources have
PLAIV vaccine approved by the Thai with respect to functional foods and solidified the country’s reputation as the
FDA in 2011, followed by the “FluVac” molecular nutrition, both novel scientific leading global supplier of agriculture
H5N2 and the IIV seasonal vaccines
currently under clinical trials and
paradigms that challenge traditional
nutrition approaches.
products such as cassava, sugarcane
and palm oil. These commodities, as 2nd
an establishment of an industrial- well as their waste byproducts, can be World’s No.2
scale influenza vaccine production Stem Cell Technology utilized as biomass which is a critical sugar
exporter
plant in Saraburi province have source for biobased energy and other
clearly demonstrated the successful Thailand is one of the leaders in stem biobased products.
accomplishment of GPO in influenza cell research in Southeast Asia. Many
vaccine production. well-known stem cell studies has been
conducted by both public and private Thailand’s Biodiversity at a Glance
Natural Product Research institutions. For instance, Chulalongkorn
in Thailand University successfully produced Located in the heart of the ASEAN region and the Indo-Burma biodiversity hub,
human embryonic stem cells, Police Thailand has one of the world’s richest biodiversities with over 13,500 species of
Functional Food General Hospital developed adult stem plants, 52% of which are endemic.1
Thai scientists have begun investigating cells to treat arthritis sufferers while
the subtle action of biologically active Siriraj Hospital discovered a method to
food components on human health. extract stem cells from human amniotic Indo-Burma region’s No.1
Additional research aims to validate the fluid. Thailand is also one of the leaders largest plant biodiversity area
efficacy of these food components and in stem-cell banking. Currently, there
establish appropriate dietary levels. Thai are five leading stem-cell banking
researchers have identified companies in Thailand. In 2012, the
country first embryonic stem-cell bank
8 - 10% of the world’s
functional food components that may was established by Chulalongkorn micro-organism species
improve memory, reduce arthritis, lessen University (supported by TCELS).
Source:
1
Thailand Advanced Institute of Science and Technology
2
National Center for Genetic Engineering and Biotechnology
Note: Strong Supply Chain
* Exchange Rate = THB 34.8/ US$
as of 1st September 2016 To establish a successful Bioeconomy model will be used as a masterplan,
supply chain, the government is focusing on R&D and collaboration
committed to playing a vital role among the different sectors, applying
in directing the national agenda. this experience to Bioeconomy, the
The successful Eastern Seaboard country’s next leading industry.
Source:
1
Office of the Higher Education Commission
2
The National Center for Genetic Engineering
and Biotechnology (BIOTEC)
3
Thailand Advanced Institute of
Science and Technology
Associations and Institutions
BOI recognizes the importance and value of the bioeconomy industry, and
offers a wide range of tax and non-tax incentives for projects that meet national
development objectives.
Non-Tax Incentives
These activities also receive the following non-tax incentives: Bioplastics
Permit to take or INCENTIVES
Permit to bring in
Permit to own land remit foreign currency
expatriates GROUP ELIGIBLE ACTIVITIES Corporate Exemption
abroad income tax of import
exemption duty*
REGIONAL OFFICES
REGIONAL INVESTMENT AND ECONOMIC CENTER 1 REGIONAL INVESTMENT AND ECONOMIC CENTER 4
CHIANG MAI OFFICE CHONBURI
Airport Business Park 108-110, 46 Moo 5 Laem Chabang Industrial Estate, Sukhumvit Road,
90 Mahidol Road, Amphur Muang, Chiang Mai 50100 Toongsukhla, Sriracha, Chonburi 20230
Tel: +66 (0) 5329 4100 Tel: +66 (0) 3840 4900
Fax: +66 (0) 5329 4199 Fax: +66 (0) 3840 4997, +66 (0) 3840 4999
Email: chmai@boi.go.th Email: chonburi@boi.go.th
OVERSEAS OFFICES
SHANGHAI MUMBAI
Thailand Board of Investment, Shanghai Office Thailand Board of Investment, Mumbai Office
Royal Thai Consulate General, No. 18, Wanshan Road, Express Tower, 12th Fl., Barrister Rajni Patel Marg,
Changning Distric, Shanghai 200336, P.R.C. Nariman Point, Mumbai, Maharashtra 400021
Tel: +86-21-5260-9876, +86-21-5260-9877 Tel: +91-22-2204-1589-90
Fax: +86-21-5260-9873 Fax: +91-22-2282-1525
Email: shanghai@boi.go.th Email: mumbai@boi.go.th